Disseminated tuberculosis with severe immune thrombocytopenia
نویسندگان
چکیده
منابع مشابه
Severe immune hemolytic anemia in disseminated tuberculosis with response to antituberculosis therapy.
Severe hemolytic anemia in patients with disseminated tuberculosis is exceedingly rare. We report an episode of Coombs'-positive hemolytic anemia in a previously healthy young man with miliary tuberculosis, resulting in a hemoglobin level of 5 g/dL and an undetectable haptoglobin level. The patient responded well to treatment with antituberculosis drugs, and the results of the direct Coombs' te...
متن کاملSevere immune thrombocytopenia during formestane treatment.
Formestane is a new aromatase inhibitor used as second-line endocrine treatment for postmenopausal women with advanced breast cancer. The most frequent side effects are local reactions. Here we report the development of immune thrombocytopenia coinciding with administration of this drug.
متن کاملImmune thrombocytopenia associated with pleural and pericardial tuberculosis: case report
uberculosis (TB) remains a major global health problem, esponsible for the ill health of millions of people each year, nd ranks as the second leading cause of death from an nfectious disease worldwide.1 A variety of clinical manifesations are associated directly or indirectly with TB. Among hem, hematological abnormalities can be found in both he pulmonary and extrapulmonary forms of the diseas...
متن کاملRomiplostim as early treatment of immune thrombocytopenia with severe immunodeficiency
Immunosuppressive agents are the standard therapeutic approach for immune thrombocy-topenia (ITP). Their prolonged use may increase the risk of infectious complications, particularly when the patient is already at higher infectious risk. In this setting, the use of drugs with a mechanism of action alternative to immunosuppression, like thrombopoietin receptor agonists (TRAs), may find particula...
متن کاملSunitinib Induced Immune Thrombocytopenia
Sunitinib is an oral tyrosine kinase inhibitor which prevents tumor growth and metastatic progression. It was approved for treatment of advanced renal cell cancer, gastrointestinal stromal tumor and advanced pancreatic neuroendocrine tumors. It has several adverse reactions on multi organ systems including hematologic system. Although the neutropenia and thrombocytopenia commonly happens as Gra...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Respiratory Medicine Case Reports
سال: 2019
ISSN: 2213-0071
DOI: 10.1016/j.rmcr.2019.02.013